Erosive reflux esophagitis

Drug	Drug Name	Drug Description
DB01129	Rabeprazole	A proton pump inhibitor used to help gastrointestinal ulcers heal, to treat symptoms of gastroesophageal reflux disease (GERD), to eradicate Helicobacter pylori, and to treat hypersecretory conditions such as Zollinger-Ellison Syndrome.

Drug	Drug Name	Target	Type
DB01129	Rabeprazole	Potassium-transporting ATPase alpha chain 1	target
DB01129	Rabeprazole	Cytochrome P450 3A4	enzyme
DB01129	Rabeprazole	Cytochrome P450 2C19	enzyme
DB01129	Rabeprazole	ATP-binding cassette sub-family G member 2	transporter
DB01129	Rabeprazole	Cytochrome P450 1A1	enzyme
DB01129	Rabeprazole	Cytochrome P450 1A2	enzyme
DB01129	Rabeprazole	Cytochrome P450 2C9	enzyme
DB01129	Rabeprazole	Cytochrome P450 2D6	enzyme
DB01129	Rabeprazole	Cytochrome P450 2C8	enzyme

Drug	Drug Name	Phase	Status	Count